Study title:
Garaventa-A, Haupt-R, Panarello-C, Dodero-P, Gambini-C, Gambaro-M.
Department of Pediatric Haematology/Oncology, G. Gaslini Children's Hospital, Genova, Italy.
Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease.
Medical and pediatric oncology, {Med-Pediatr-Oncol}, Mar 2001, vol. 36, no. 3, p. 396-7, ISSN: 0098-1532.Garaventa-A, Haupt-R, Panarello-C, Dodero-P, Gambini-C, Gambaro-M.
Department of Pediatric Haematology/Oncology, G. Gaslini Children's Hospital, Genova, Italy.
Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease.
Medical and pediatric oncology, {Med-Pediatr-Oncol}, Mar 2001, vol. 36, no. 3, p. 396-7, ISSN: 0098-1532.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|